about
Fcγ and Complement Receptors and Complement Proteins in Neutrophil Activation in Rheumatoid Arthritis: Contribution to Pathogenesis and Progression and Modulation by Natural ProductsPathogenesis and prevention of rheumatic disease: focus on preclinical RA and SLEUnderstanding emerging treatment paradigms in rheumatoid arthritisA randomized placebo-controlled trial of methotrexate in psoriatic arthritisReal-world effectiveness of abatacept for rheumatoid arthritis treatment in European and Canadian populations: a 6-month interim analysis of the 2-year, observational, prospective ACTION study.Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial.
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Disease activity measures for rheumatoid arthritis.
@en
type
label
Disease activity measures for rheumatoid arthritis.
@en
prefLabel
Disease activity measures for rheumatoid arthritis.
@en
P2093
P1476
Disease activity measures for rheumatoid arthritis.
@en
P2093
P433
5 Suppl 46
P577
2007-09-01T00:00:00Z